Saudi Arabia Molecular Diagnostics Market Size Share Trends Growth Report 2025-2033

The Saudi Arabia molecular diagnostics market size reached USD 188.10 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 330.56 Million by 2033, exhibiting a growth rate (CAGR) of 5.80% during 2025-2033.

Saudi Arabia Molecular Diagnostics Market Overview

Market Size in 2024: USD 188.10 Million

Market Size in 2033: USD 330.56 Million

Market Growth Rate 2025-2033: 5.80%

According to IMARC Group's latest research publication, "Saudi Arabia Molecular Diagnostics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The Saudi Arabia molecular diagnostics market size reached USD 188.10 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 330.56 Million by 2033, exhibiting a growth rate (CAGR) of 5.80% during 2025-2033.

How AI is Reshaping the Future of Saudi Arabia Molecular Diagnostics Market

Revolutionizing Disease Detection and Diagnosis: AI-powered algorithms are transforming molecular diagnostic accuracy through automated pattern recognition, deep learning analysis of genomic sequences, and intelligent interpretation of PCR results, improving diagnostic precision by 17% while reducing turnaround times from days to hours across Saudi healthcare facilities, supporting the Kingdom's USD 13.3 billion healthcare investment announced in 2024.
Enhancing Precision Medicine and Personalized Treatment: Machine learning platforms integrated with next-generation sequencing (NGS) are enabling personalized medicine approaches through predictive analytics, biomarker identification, and treatment response forecasting, supporting Saudi Arabia's Human Genome Program and advancing the Kingdom's position as a regional leader in genomics-based healthcare under Vision 2030 initiatives.
Optimizing Laboratory Workflow Automation: AI-driven laboratory information systems are revolutionizing molecular testing operations through intelligent sample tracking, automated quality control, predictive maintenance of diagnostic equipment, and optimized resource allocation, reducing operational errors by 30-40% while increasing laboratory throughput capacity across the expanding network of diagnostic centers in Riyadh, Jeddah, and other major cities.
Accelerating Drug Discovery and Development: Artificial intelligence platforms are transforming pharmaceutical research through molecular modeling, drug-target interaction prediction, and clinical trial optimization, supporting Saudi Arabia's growing biotechnology sector and attracting international partnerships like the Abu Dhabi-GSK collaboration to establish medical institutes focused on integrating genomics data for cancer research across the Gulf region.
Facilitating Telemedicine and Remote Diagnostics: AI-powered digital health platforms are enabling remote molecular diagnostic consultations, real-time test result interpretation, and virtual genetic counseling services, supporting the expansion of Saudi Arabia's digital health market projected to reach USD 16.94 billion by 2033 at a CAGR of 23.81%, while improving access to specialized diagnostic services across rural and underserved regions.

Grab a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-molecular-diagnostics-market/requestsample

Saudi Arabia Molecular Diagnostics Market Trends & Drivers:

Saudi Arabia's molecular diagnostics market is experiencing robust growth driven by the government's ambitious Vision 2030 healthcare modernization initiatives, with the Kingdom allocating USD 36.8 billion to healthcare and social development in 2022, representing 14.4% of the national budget and positioning Saudi Arabia as responsible for approximately 60% of total healthcare spending across the Gulf Cooperation Council. The establishment of specialized medical cities and promotion of public-private partnerships is accelerating diagnostic infrastructure development, with AKDITAL Group announcing a USD 200 million investment in 2025 to build private hospitals in Riyadh and Jeddah by 2027, featuring advanced molecular testing as an integral component of standard care.

The surge in medical tourism ambitions is creating unprecedented demand for international-standard molecular diagnostic capabilities, with Saudi Arabia's medical tourism sector valued at USD 1,341.1 million in 2024 and projected to reach USD 7,918.6 million by 2033 at a CAGR of 21.80%. Tertiary hospitals and emerging medical cities are incorporating advanced PCR, NGS, and molecular oncology testing to attract international patients from the GCC and broader MENA region seeking specialized services in oncology, fertility, and genetic counseling, with screening coverage for breast and colorectal cancer currently below 25% of eligible populations, creating significant opportunities for minimally invasive molecular diagnostics.

Strategic international partnerships and technology localization initiatives are accelerating market expansion, exemplified by Co-Diagnostics' October 2025 joint venture with Arabian Eagle Manufacturing to establish CoMira Diagnostics, which will manufacture and distribute Co-Dx PCR platforms across Saudi Arabia and 18 other MENA countries. The Saudi AI diagnostics market is projected to grow from USD 17 million in 2022 to USD 204.9 million by 2030 at a CAGR of 36.5%, while the broader Saudi In Vitro Diagnostics market reached USD 757 million in 2024 with molecular diagnostics experiencing rapid adoption. Major developments include the June 2024 Abu Dhabi-Illumina partnership to incorporate NGS into clinical workflows, the May 2024 launch of OncoHelix-coLAB at Burjeel Medical City for comprehensive genomic profiling, and the November 2024 Recursive AI-KAIMRC MoU for AI-powered tuberculosis screening, positioning Saudi Arabia as a regional hub for molecular diagnostic innovation and supporting the Kingdom's goal to extend life expectancy to 83 years while managing the rising burden of chronic diseases affecting up to 20% of the GCC population.

Saudi Arabia Molecular Diagnostics Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

Reagents and Kits
Instruments
Software and Services

Technology Insights:

Polymerase Chain Reactions (PCR)
Hybridization
DNA Sequencing
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others

Application Insights:

Infectious Diseases Diagnostics
Oncology
Genetic Testing
Blood Screening
Others

End User Insights:

Hospitals
Laboratories
Others

Breakup by Region:

Northern and Central Region
Western Region
Eastern Region
Southern Region

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Recent News and Developments in Saudi Arabia Molecular Diagnostics Market

October 2025: Co-Diagnostics signed a definitive agreement with Arabian Eagle Manufacturing to establish CoMira Diagnostics joint venture in Saudi Arabia, focusing on research, development, manufacturing, and commercialization of Co-Dx PCR platforms across KSA and 18 other MENA countries, aligning with Vision 2030's technology localization and healthcare innovation priorities.
August 2024: Saudi Arabia's Ministry of Health launched the Regulatory Healthcare Sandbox, a digital health service platform designed to accelerate innovation by offering startups and companies a secure environment to test and refine molecular diagnostics, AI solutions, and digital health technologies for integration into the national healthcare system.
June 2024: The Abu Dhabi Department of Health formalized a strategic partnership with Illumina to incorporate next-generation sequencing (NGS) and multi-omics into clinical workflows across the Gulf region, improving clinician training and assessing the economic benefits of precision health adoption, while Burjeel Medical City launched OncoHelix-coLAB in May 2024 for comprehensive genomic profiling.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302